Summary of mechanical thrombectomy phase I trials
| Study | No of patients | Baseline NIHSS (mean) | Recanalized (TIMI 2 or 3) | Median time from start of procedure to recanalization (min) | Favorable outcome at last follow-up (mRS 0–2) |
|---|---|---|---|---|---|
| Wingspan3 | 20 | 14±4 | 20 (100%) | 45 | 11 (55%), 30 days |
| Solitaire4 | 20 | 19±7 | 18 (90%) | 70 | 9 (45%), 90 days |
| Penumbra5 | 20 | 21±8 | 20 (100%) | NA | 7 (35%), 30 days |
| Trevo6 | 60 | NA | 55 (92%) | NA | 33 (55%), 90 days |
| Enterprise (present series) | 20 | 16±1 | 18 (90%) | 40 | 10 (50%), 30 days |
mRS, modified Rankin scale (score); NIHSS, National Institutes of Health Stroke Scale (score); TIMI, Thrombolysis in Myocardial Infarction.